Pediatric acute myeloid leukemia in Uruguay: clinical outcomes and diagnostic challenges in a national cohort (2008–2024)
Pediatric AML survival in Uruguay remains below international benchmarks, mainly due to treatment-related mortality during induction. Implementation of CHIP-AML22, together with stronger induction management and supportive care, offers opportunities to improve survival and narrow this gap.
Authors
- Anaulina Silveira (ORCID: https://orcid.org/0000-0003-3296-363X)
- Gabriel Dapueto
- Gertjan J.L. Kaspers (ORCID: https://orcid.org/0000-0001-7716-8475)
- Magdalena Schelotto (ORCID: https://orcid.org/0000-0001-8723-1239)
- Luis Castillo (ORCID: https://orcid.org/0000-0003-2880-0838)
- Lucía D’Andrea
- Inés Pereira
Institutions
- Centro Hospitalario Pereira Rossell (UY)
- Emma Kinderziekenhuis (NL)
- Princess Máxima Center (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1080/14737140.2025.2604165
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00